주식/증권 📉 부정적

CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing

Yahoo Finance 2026/09/22 14:43:19 28회

요약

The FDA wants Compass to conduct a trial showing Tovecimig can improve overall survival in patients with previously treated, advanced biliary tract cancer.

원문 기사 보기

관련 뉴스

Stellantis Q3 shipments slip to 1.3M units amid North American slump

2026/10/13

Germany's inflation climbs to 3.3% as energy costs jump

2026/10/13

Tencent prepares $4.5B+ dollar and yuan bond offering for AI capex

2026/10/13

SpaceXAI bundles Grok, Cursor, and X features into unified subscription tiers

2026/10/13

뉴스 목록으로